|
Findings From the Northwestern Juvenile Project
The study reported in this Bulletin uses self-report and urinalysis
results from the Northwestern Juvenile Project to compare the veracity
of self-reported drug use across demographic groups and to identify the
best approach for assessing drug use among juvenile detainees. The study
focuses on self-report and urinalysis for three reasons: they are the
most widely used, best understood measures of substance use; they can
be administered by trained lay personnel (a practical consideration for
juvenile justice facilities); and the level of agreement and disagreement
between the two measures is relatively well documented.
This section describes the studys sample and methods, presents
an overview of findings, and then looks at findings for the two substances
most commonly used by juvenile detaineescannabis and cocaineby
subject characteristics (gender, race/ethnicity, age, prior treatment
for substance abuse, and recent drug charges).
Sample and Methods
Sample. The Northwestern Juvenile Project is an ongoing longitudinal
study of high-risk youth sampled from the Cook County Juvenile Temporary
Detention Center (CCJTDC) in Chicago, IL. CCJTDC was selected for study
because of its urban location (most juvenile detainees nationwide are
in urban areas) and because Cook County is ethnically diverse and has
a large Hispanic population (Hispanics are the largest minority group
in the United States and are overrepresented in the juvenile justice
system). In addition, CCJTDCs size (approximately 8,500 admissions
each year, daily census of 650, and daily intake of 20) ensured adequate
numbers of subjects for key subgroups such as females and Hispanics.
The CCJTDC sample was stratified by gender, race/ethnicity (African
American, non-Hispanic white, Hispanic), age (1013 or 14 and older),
and legal status (processed as a juvenile or as an adult). All estimates
reported in this Bulletin were weighted to reflect the CCJTDC sample
(Little and Schenker, 1995; Cochran, 1977).
Initial sampling and baseline interviews were conducted between November
1995 and June 1998. The final sample size for the project was 1,829.
Additional information on the sample and study design is available elsewhere
(Teplin et al., 2002; Abram et al., 2003; Teplin et al., 2003).
Interviews and urine samples. Trained interviewers used the Diagnostic
Interview Schedule for Children (DISC 2.3) to gather information on substance
use. Subjects were assured that the information they revealed would remain
confidential and would have no bearing on their legal proceedings. Interviewers
built rapport with subjects during the questions that preceded the substance
use items (basic demographic information, education, life circumstances,
and DISC mental health items). Female subjects were assigned female interviewers,
and Spanish-speaking subjects were assigned bilingual interviewers.
The DISC instrument measures use of alcohol, cannabis/hashish, uppers/speed,
downers (e.g., barbiturates), tranquilizers (e.g., Valium, Librium, and
Ativan), heroin and opiates (including morphine, methadone, and codeine),
cocaine/crack cocaine, hallucinogens (including LSD and PCP), and inhalants
(e.g., glue). The instrument asks about lifetime use, age at first use,
frequency of use in the past year, any use in the past 6 months, and
treatment. Because it is designed to assess patterns of use, it does
not ask about use in the past 2 or 3 days.
Of the 1,829 subjects interviewed, 1,745 (about 95 percent) provided
urine samples.6 Some subjects were unwilling
or unable to provide samples, and some samples were unavailable for administrative
reasons.7 The final sample size for the analyses
reported in this Bulletin is 1,742 (3 subjects did not complete the DISC
portion of the interview).8
Urinalysis. Enzyme-Multiplied Immunoassay Tests (EMIT) were
used to identify illicit drug use by the subjects. The EMIT10 panel
tests for the presence of amphetamines, barbiturates, benzodiazepines
(diazepam, nordiazepam, oxazepam, chlordiazepoxide, and norflurazepam),
cannabis, cocaine (benzoylecgonine is a cocaine metabolite found in
the urine), methaqualone (Quaaludes), opiates (including codeine and
morphine), PCP, and propoxyphene (Darvon). Some EMIT10 panel categories
are not exact matches for self-report categories.9
Drug charges. Data on recent drug charges (e.g., possession or
sale of controlled substances) against subjects were collected from the
Cook County Court Clerks computer system. The period of coverage
for these data was from 90 days prior to intake at CCJTDC to 30 days
after intake (to account for lagtime between arrests and charges).
Overview of Findings
Table 2 presents an overview of findingsself-reported use, urinalysis
results, and computations of veracity, prevalence, and bias (see Definitions sidebar)among the total sample of all detained juveniles.
Table 2: Drug Use by Detained Juveniles in Cook County, IL: Overview
of Findings (%)
| |
Self-Reported Substance Use
|
Substance
Detected by Urinalysis |
Veracity |
Minimum Prevalence |
Minimum Bias
for Self-Reporting |
Minimum Bias
for Urinalysis |
Drug |
6-Month
|
Lifetime |
6-Month |
Lifetime |
6-Month |
Lifetime |
6-Month |
Lifetime |
6-Month |
Lifetime |
| Any
substance |
77.3 |
90.1 |
66.4 |
87.7 |
94.1 |
85.4 |
94.0 |
8.2 |
3.9 |
19.0 |
27.6 |
| Cannabis |
77.1 |
90.1 |
65.9 |
87.6 |
94.1 |
85.3 |
94.0 |
8.2 |
3.9 |
19.4 |
28.1 |
| Other
than cannabis |
8.0 |
13.0 |
5.8 |
27.5 |
37.8 |
12.2 |
16.6 |
4.2 |
3.6 |
6.4 |
10.9 |
| Cocaine |
4.4 |
6.2 |
4.8 |
21.7 |
28.1 |
8.1 |
9.6 |
3.6 |
3.4 |
3.4 |
4.8 |
| Opiates |
1.2 |
2.6 |
0.2 |
65.7 |
65.7 |
1.3 |
2.6 |
0.1 |
0.1 |
1.1 |
2.5 |
| Uppers |
0.8 |
1.8 |
0.0 |
|
|
0.8 |
1.8 |
|
|
|
|
| Downers |
0.3 |
0.5 |
0.0 |
|
|
0.3 |
0.5 |
|
|
|
|
| Tranquilizers |
0.3 |
0.6 |
0.0 |
|
|
0.3 |
0.6 |
|
|
|
|
| Hallucinogens |
5.5 |
9.4 |
1.1 |
33.3 |
39.3 |
6.1 |
10.1 |
|
|
|
|
Note: N=1,742.
For explanations of veracity, minimum prevalence, and minimum bias,
see Definitions sidebar.
* Veracity cannot be computed because the EMIT urinalysis result
is zero.
Bias figures are not presented because
self-reported use is very limited and bias computations would
not, therefore, be meaningful.
Bias figures are not presented because
the EMIT urinalysis panel detects PCP but not the other hallucinogens
in the DISC self-report instrument and bias computations would,
therefore, be misleading. |
Self-reported use. Self-reported use of any substance was quite
common. Use in the past 6 months was reported by 77.3 percent of youth,
lifetime use by 90.1 percent. The figures for cannabis were about the
same (77.1 percent and 90.1 percent, respectively), an indication that
almost all youth who report any substance use report cannabis use. Self-reported
use of substances other than cannabis was much less common: 8.0 percent
and 13.0 percent (6-month and lifetime, respectively) for any other substance,
5.5 percent and 9.4 percent for hallucinogens, 4.4 percent and 6.2 percent
for cocaine, and even less for the other categories measured (opiates,
uppers, downers, and tranquilizers).
Definitions
The measures
reported in tables 2, 3, and 4 and analyzed in the accompanying
text are defined below.
Self-reported use: percentage of detained
youth who reported substance use.
Urinalysis results: percentage
of detained youth who tested positive for substances in
EMIT10
urinalysis.
Veracity: percentage of detained youth
who tested positive by urinalysis who also reported use.
Minimum
prevalence: estimated prevalence of substance use among
detained youth, based on combined self-report and urinalysis
results.
Minimum
bias for self-report: estimated percentage of detained
youth who use drugs and would go undetected if self-report
is used without urinalysis (calculated as the difference
between minimum prevalence and self-reported use).
Minimum bias for urinalysis: estimated
percentage of detained youth who use drugs and would go undetected
if urinalysis is used without self-report (calculated as
the difference between minimum prevalence and urinalysis
results).
Self-reported use and the related measures of veracity,
prevalence, and bias are presented separately for use in
the past 6 months and ever (lifetime). Prevalence and bias
estimates are minimum because
both self-report and urinalysis measures are expected to
underestimate true rates of substance use. |
|
Urinalysis results. In many ways, patterns of use
detected by EMIT10 urinalysis were similar to patterns of self-reported use.
However, use rates based on urinalysis results generally were lower than
those based on self-reports of 6-month and lifetime use. This is not
surprising, given that in urinalysis, the window of sensitivity to drugs
generally is only 23 days. Two-thirds (66.4 percent) of detainees
tested positive for any drug, 65.9 percent for cannabis, 5.8 percent
for any substance other than cannabis, 4.8 percent for cocaine, and 1.1
percent for hallucinogens.
Veracity. Overall, self-reporting had a surprisingly high level
of veracity. Among all detainees with positive urinalysis results, 87.7
percent reported use of any substance in the past 6 months and 94.1 percent
reported lifetime use of any substance. However, although the veracity
figures for cannabis (87.6 percent for 6 months and 94.1 percent for
lifetime) were nearly identical to the overall figures, those for any
drug other than cannabis were much lower (27.5 percent and 37.8 percent).
This means that cannabis alone was responsible for the high level of
veracity in self-reporting of overall drug use. More than three in five
detainees who tested positive for use of illicit substances other than
cannabis did not accurately report their use.
Minimum prevalence. Based on a combination of self-report and
urinalysis results, the minimum prevalence estimates show that at least
85.4 percent of detained youth had used some kind of illicit substance
in the past 6 months and at least 94 percent had used an illicit substance
at some point in their lifetime. For substances other than cannabis,
however, minimum prevalence was much lower: 12.2 percent for 6 months
and 16.6 percent for lifetime.
Minimum bias for self-report. This measure, which is the difference
between the minimum prevalence estimate and the self-report estimate,
indicates that self-reporting without urinalysis overlooked at least
8.2 percent of detained youth who had used some kind of illicit substance
in the past 6 months, or almost 1 in 10 youth in detention. This bias
drops to 3.9 percent for lifetime use. For substances other than cannabis,
self-reporting without urinalysis overlooked 4.2 percent of youth who
had used a substance in the past 6 months and 3.6 percent of those with
lifetime use. These values were low because overall use of these substances
was low. Nevertheless, as the bias and prevalence figures show, self-reporting
overlooked one-fourth (3.6/16.6) to one-third (4.2/12.2) of juveniles
who had used substances other than cannabis.
For cocaine specifically, 6-month self-reporting overlooked 3.6 percent
of detainees and lifetime self-reporting overlooked 3.4 percent of detainees.
The 6-month minimum prevalence for cocaine use was only 8.1 percent,
so overlooking 3.6 percent means missing more than one-third of confirmed
cocaine users.
For uppers, downers, and tranquilizers, self-reported use was less than
2 percent and EMIT urinalysis findings were zero. Therefore, veracity
could not be computed for these substances, and table 2 does not present
self-report bias figures for them.
Because very few detainees tested positive for hallucinogens, very few
users of hallucinogens would be missed by self-reporting alone. As noted
in endnote 9, the EMIT panel detects PCP but not the other hallucinogens
in the DISC questionnaire. Therefore, the minimum prevalence estimates
for hallucinogens (6.1 percent and 10.1 percent for 6-month and lifetime
use, respectively) are biased downward relative to estimates for the
other categories of substances. For these reasons, table 2 does not present
self-report bias figures for hallucinogens.
Minimum bias for urinalysis. Minimum biases were greater for
urinalysis than for self-reporting, in part because urinalysis has a
limited window of sensitivity to drugs. When not combined with self-reporting,
urinalysis overlooked one in five detained youth (19.0 percent) who reported
using any substance in the past 6 months and one in four (27.6 percent)
who reported lifetime use. For substances other than cannabis, urinalysis
overlooked 6.4 percent of self-reported 6-month users and 10.9 percent
of lifetime users. Table 2 does not present urinalysis bias figures for
uppers, downers, tranquilizers, and hallucinogens for the same reasons
it does not present self-report bias figures for these substances (see
above). (The urinalysis bias for hallucinogens was quite large, but this
is probably because of the limited scope of the EMIT test for hallucinogens.)
Age at Onset of Substance Use
Juvenile
detainees who reported using drugs were asked about age at
first use. Their response is disturbing. Ten percent of the
youth who reported using drugs said they first used them at
or before age 11, and 25 percent reported first use at or before
age 12. Ten percent of youth who reported using cocaine said
they first used it before age 11, and 50 percent reported first
use before age 15. |
|
Analysis: Cannabis
This section analyzes findings for cannabis. See table 3 and Definitions sidebar.
Table 3: Drug Use by Detained Juveniles in Cook County, IL: Analysis
of Findings for Cannabis (%)
| |
Self-Reported
Substance Use |
Substance Detected by Urinalysis |
Veracity |
Minimum Prevalence |
Minimum
Bias for Self-Reporting |
Minimum
Bias for Urinalysis |
|
| |
6-Month |
Lifetime |
6-Month |
Lifetime |
6-Month |
Lifetime |
6-Month |
Lifetime |
6-Month |
Lifetime |
N |
MALE |
77.3 |
90.2 |
67.4 |
87.6 |
94.2 |
85.7 |
94.1 |
8.4 |
3.9 |
18.2 |
26.7 |
1,126 |
Race |
| African
American |
77.1 |
89.9 |
69.9 |
86.8 |
93.7 |
86.3 |
94.3 |
9.2 |
4.4 |
16.4 |
24.4 |
552 |
| Non-Hispanic
white |
81.0 |
91.7 |
59.5 |
94.6 |
97.8 |
84.2 |
93.0 |
3.2 |
1.3 |
24.4 |
33.6 |
199 |
| Hispanic |
78.1 |
91.6 |
58.9 |
91.1 |
97.3 |
83.3 |
93.2 |
5.2 |
1.6 |
24.4 |
34.3 |
372 |
Age |
| 1013 |
56.7 |
70.3 |
46.6 |
70.5 |
81.4 |
70.5 |
79.0 |
13.8 |
8.7 |
23.9 |
32.3 |
306 |
| 1415 |
75.5 |
88.2 |
69.0 |
85.0 |
90.6 |
85.9 |
94.6 |
10.4 |
6.5 |
16.9 |
25.7 |
344 |
| 16+ |
82.5 |
95.6 |
70.0 |
91.8 |
98.7 |
88.3 |
96.5 |
5.7 |
0.9 |
18.2 |
26.5 |
476 |
Prior
treatment |
| No |
95.6 |
98.2 |
74.8 |
97.5 |
99.0 |
97.4 |
99.0 |
1.8 |
0.7 |
22.6 |
24.2 |
616 |
| Yes |
99.3 |
99.7 |
87.9 |
100.0 |
100.0 |
99.3 |
99.7 |
0.0 |
0.0 |
11.4 |
11.9 |
158 |
Recent
drug charges |
| None |
74.7 |
88.5 |
60.6 |
88.2 |
95.0 |
81.8 |
91.5 |
7.1 |
3.0 |
21.2 |
30.9 |
857 |
| Any |
82.4 |
93.6 |
81.2 |
86.5 |
93.0 |
93.4 |
99.3 |
10.9 |
5.7 |
12.1 |
18.1 |
269 |
| 2+ |
84.9 |
97.7 |
77.5 |
89.8 |
98.8 |
92.8 |
98.6 |
7.9 |
0.9 |
15.3 |
21.1 |
87 |
FEMALE |
75.1 |
88.5 |
45.5 |
88.6 |
92.7 |
80.3 |
91.8 |
5.2 |
3.3 |
34.9 |
46.4 |
616 |
Race |
| African
American |
71.6 |
86.1 |
46.1 |
87.1 |
90.8 |
77.6 |
90.3 |
6.0 |
4.2 |
31.5 |
44.2 |
404 |
| Non-Hispanic
white |
85.4 |
96.3 |
47.5 |
92.3 |
97.4 |
89.0 |
97.6 |
3.7 |
1.2 |
41.6 |
50.1 |
81 |
| Hispanic |
81.2 |
93.1 |
46.6 |
93.0 |
97.8 |
84.5 |
94.1 |
3.3 |
1.0 |
37.9 |
47.5 |
130 |
Age |
| 1013 |
50.8 |
68.3 |
22.4 |
71.1 |
71.1 |
57.3 |
74.8 |
6.5 |
6.5 |
34.9 |
52.4 |
50 |
| 1415 |
76.5 |
89.1 |
44.8 |
90.4 |
93.6 |
80.8 |
92.0 |
4.3 |
2.9 |
36.0 |
47.1 |
334 |
| 16+ |
78.4 |
92.1 |
51.2 |
88.1 |
93.7 |
84.5 |
95.3 |
6.1 |
3.3 |
33.3 |
44.1 |
232 |
Prior
treatment |
| No |
94.4 |
98.5 |
55.5 |
98.9 |
99.4 |
95.0 |
98.8 |
0.6 |
0.3 |
39.4 |
43.3 |
311 |
| Yes |
97.8 |
100.0 |
57.4 |
97.8 |
100.0 |
99.1 |
100.0 |
1.3 |
0.0 |
41.7 |
42.6 |
94 |
Recent
drug charges |
| None |
74.2 |
88.0 |
42.6 |
89.4 |
93.1 |
78.7 |
91.0 |
4.5 |
2.9 |
36.1 |
48.4 |
547 |
| Any |
82.6 |
92.4 |
67.2 |
84.7 |
90.9 |
92.8 |
98.5 |
10.2 |
6.1 |
25.7 |
31.3 |
69 |
| 2+ |
86.7 |
92.2 |
67.9 |
88.5 |
88.5 |
94.5 |
100.0 |
7.8 |
7.8 |
26.6 |
32.1 |
14 |
| Note:
For explanations of veracity, minimum prevalence, and minimum bias,
see Definitions sidebar. |
Gender
- Although self-reported use of cannabis was about the same for boys
and girls (around 75 percent for 6-month use and 90 percent for lifetime
use), urinalysis results differed dramatically: 67.4 percent for boys
and 45.5 percent for girls. This suggests either that cannabis use
was less common among girls than boys or that the temporal association
between using cannabis and being arrested was stronger for boys than
for girls.
- Veracity in reporting cannabis use was about the same for boys and
girls, i.e., most detainees with positive urinalysis results also reported
use. However, because boys had a higher rate of positive urinalysis
results, their 6-month self-report bias (8.4 percent) was greater than
that for girls (5.2 percent). In other words, cannabis use during the
past 6 months was more likely to go undetected among boys than among
girls if self-reporting was used without urinalysis. Lifetime self-report
bias was similar for boys (3.9 percent) and girls (3.3 percent).
- Urinalysis biases were much higher for girls (34.9 percent for 6
months and 46.4 percent for lifetime) than for boys (18.2 percent 6
months, 26.7 percent lifetime), which means that cannabis use would
be much more likely to go undetected among girls than among boys if
urinalysis testing is used without self-reporting. This again suggests
that recent cannabis use was less common among girls than among boys.
Race/ethnicity
- Among males, self-reported cannabis use was roughly equal for all
three racial/ethnic groups.
- Boys in all three racial/ethnic groups had reasonably good veracity
for reporting cannabis use, although 6-month veracity was slightly
lower for African American boys (86.8 percent) than for other boys
(94.6 percent for non-Hispanic whites and 91.1 percent for Hispanics).
Because the rate of positive urinalysis results was higher for African
American boys than other boys, the 6-month self-report bias was greater
for African Americans (9.2 percent) than for others (3.2 percent for
non-Hispanic whites and 5.2 percent for Hispanics).
- Among boys, urinalysis bias for detecting cannabis use was lower
for African Americans (24.4 percent for lifetime use) than for other
groups (33.6 percent for non-Hispanic whites and 34.3 for Hispanics).
The proportion of lifetime cannabis users who would be overlooked when
urinalysis is used without self-report methods is smaller for African
Americans than for other racial/ethnic groups.
- Unlike males, female detainees in the three racial/ethnic groups
differed substantially in their rates of self-reported cannabis use.
Only 71.6 percent of African American girls reported use in the past
6 months, compared with 85.4 percent of non-Hispanic whites and 81.2
percent of Hispanics. Lifetime self-report rates also were lower for
African American girls than for other girls.
- Because of the differences in self-reported use, the 6-month self-report
bias for cannabis was greater for African American girls (6 percent)
than for other girls (3.7 percent for non-Hispanic whites and 3.3 percent
for Hispanics). The 6-month urinalysis bias was greater for non-Hispanic
white girls (41.6 percent) than for African American girls (31.5 percent)
and Hispanic girls (37.9 percent). In short, self-reporting alone was
most likely to overlook cannabis use among African American girls,
whereas urinalysis alone was most likely to overlook its use among
non-Hispanic white girls. This finding suggests that among girls, African
Americans self-reports of cannabis use are the least reliable.
Age
- Among both boys and girls, self-reported cannabis use was less common
for detainees ages 1013 than for older detainees. Among detainees
ages 1013, use in the past 6 months was reported by 56.7 percent
of boys and 50.8 percent of girls (compared with 77.3 percent of all
boys and 75.1 percent of all girls).
- Among boys, biases for both self-report and urinalysis varied greatly
by age: compared with older boys, those ages 1013 had greater
biases (i.e., their cannabis use was more likely to go undetected when
either detection method was used alone). In contrast, biases among
girls did not vary greatly by age.
Prior treatment for substance abuse
- Almost all boys and girls who reported prior treatment for substance
use had very substantial self-reported cannabis use and consequently
had very low self-report bias.
- Urinalysis detection for cannabis was much more common for boys who
reported prior treatment (87.9 percent) than for girls who reported
prior treatment (57.4 percent). Because so many boys who reported prior
treatment tested positive, their urinalysis bias (11.9 percent for
lifetime use) was much smaller than that for girls who reported prior
treatment (42.6 percent for lifetime use).
Recent arrests for drug offenses
- Self-reported cannabis use and positive urinalysis results for cannabis
were more common among detainees with recent drug arrests than among
those with no recent drug arrests.
- Detainees with recent drug arrests were quite forthcoming about their
cannabis use: veracity for self-reported use in the past 6 months was
well above 80 percent for both males and females, and lifetime veracity
was above 90 percent.
- For both 6-month and lifetime use, minimum prevalence exceeded 90
percent for male and female detainees with recent drug arrests.
Analysis: Cocaine
This section analyzes findings for cocaine. Seetable 4 and Definitions sidebar.
Table 4: Drug Use by Detained Juveniles in Cook County, IL: Analysis
of Findings for Cocaine (%)
| |
Self-Reported
Substance Use |
Substance Detected by Urinalysis |
Veracity |
Minimum Prevalence |
Minimum Bias
for Self-Reporting |
Minimum
Bias for Urinalysis |
|
| |
6-Month |
Lifetime |
6-Month |
Lifetime |
6-Month |
Lifetime |
6-Month |
Lifetime |
6-Month |
Lifetime |
N |
MALE |
4.0 |
5.7 |
4.9 |
20.8 |
27.4 |
7.8 |
9.2 |
3.7 |
3.5 |
3.0 |
4.3 |
1,126 |
Race |
| African American |
0.4 |
0.5 |
3.2 |
0.0 |
0.0 |
3.7 |
3.8 |
3.2 |
3.2 |
0.4 |
0.5 |
552 |
| Non-Hispanic
white |
21.5 |
29.5 |
7.7 |
61.5 |
78.6 |
24.3 |
31.2 |
2.8 |
1.6 |
17.1 |
23.5 |
199 |
| Hispanic |
16.2 |
23.1 |
12.1 |
42.0 |
52.7 |
22.8 |
28.8 |
6.6 |
5.7 |
11.5 |
16.7 |
372 |
Age |
| 1013 |
1.0 |
1.6 |
2.1 |
5.9 |
5.9 |
3.0 |
3.6 |
2.0 |
2.0 |
0.9 |
1.5 |
306 |
| 1415 |
3.2 |
4.5 |
4.5 |
16.0 |
19.8 |
6.8 |
8.1 |
3.6 |
3.6 |
2.5 |
3.6 |
344 |
| 16+ |
5.3 |
7.4 |
5.7 |
25.0 |
33.9 |
9.5 |
11.2 |
4.2 |
3.8 |
3.9 |
5.5 |
476 |
Prior treatment |
| No |
4.7 |
6.6 |
4.4 |
24.9 |
31.9 |
7.9 |
9.6 |
3.2 |
3.0 |
3.6 |
5.2 |
616 |
| Yes |
10.0 |
12.9 |
9.1 |
33.0 |
38.1 |
15.7 |
18.6 |
5.7 |
5.7 |
7.2 |
9.4 |
158 |
Recent drug
charges |
| None |
5.6 |
7.7 |
3.8 |
33.2 |
40.6 |
8.0 |
10.0 |
2.5 |
2.3 |
4.3 |
6.2 |
857 |
| Any |
1.0 |
1.5 |
7.0 |
7.3 |
13.0 |
7.2 |
7.6 |
6.3 |
6.1 |
0.5 |
0.6 |
269 |
| 2+ |
0.4 |
0.4 |
5.0 |
8.7 |
8.7 |
5.0 |
5.0 |
4.6 |
4.6 |
0.0 |
0.0 |
87 |
FEMALE |
9.6 |
12.4 |
3.7 |
36.2 |
39.4 |
12.0 |
14.6 |
2.4 |
2.3 |
8.3 |
10.9 |
616 |
Race |
| African American |
1.5 |
1.5 |
2.7 |
0.0 |
0.0 |
4.2 |
4.2 |
2.7 |
2.7 |
1.5 |
1.5 |
404 |
| Non-Hispanic
white |
26.7 |
44.0 |
7.3 |
83.3 |
100.0 |
28.0 |
44.0 |
1.3 |
0.0 |
20.4 |
36.7 |
81 |
| Hispanic |
24.7 |
30.2 |
| |